![Daniel Raskas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Raskas
Direktor/Vorstandsmitglied bei
ENVISTA HOLDINGS CORPORATION
Vermögen: 3 Mio $ am 31.05.2026
Profil
Daniel A. Raskas is currently Director at OTT Hydromet Corp.
(Virginia), Independent Director at Envista Holdings Corp.
since 2019, and Senior Vice President-Corporate Development at Danaher Corp.
since 2010.
Former positions include Director at Tektronix, Inc. in 2007, Director at Beckman Coulter, Inc., Director at Sybron Dental Specialties, Inc., Managing Director at Oridian Capital Partners LLC from 1998 to 2004, Managing Director at Thayer Capital Partners LP, and Mergers & Acquisitions Attorney at Arnold & Porter LLP.
Education includes graduate studies at Harvard Law School, undergraduate studies at Harvard College, and an MBA from Columbia School of International & Public Affairs.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 03.02.2025 | 10.524 ( 0 % ) | 2 Mio $ | 31.05.2026 | |
ENVISTA HOLDINGS CORP. 0,03 % | 19.05.2026 | 54.010 ( 0,03 % ) | 1 Mio $ | 31.05.2026 |
Aktive Positionen von Daniel Raskas
| Unternehmen | Position | Beginn |
|---|---|---|
| DANAHER CORPORATION | Corporate Officer/Principal | 01.11.2004 |
| SUTRON CORPORATION | Direktor/Vorstandsmitglied | - |
| ENVISTA HOLDINGS CORPORATION | Direktor/Vorstandsmitglied | 01.01.2019 |
Ehemalige bekannte Positionen von Daniel Raskas
| Unternehmen | Position | Ende |
|---|---|---|
Tektronix, Inc.
 Tektronix, Inc. Electronic Equipment/InstrumentsElectronic Technology Provides test, measurement, and monitoring solutions | Direktor/Vorstandsmitglied | 23.11.2007 |
HCI Equity Partners LLC
 HCI Equity Partners LLC Investment ManagersFinance Oridian Capital Partners invests in lower middle market companies located in the United States with an EBITDA of USD 3 - 25 million and revenues ranging USD 20 - 200 million. The firm focuses on a broad range of sectors and Industries. It participates in buyout and growth stage capital requirements with an investment size ranging from USD 15 - 75 million. It also acquires majority stake position. | Corporate Officer/Principal | 01.10.2004 |
Arnold & Porter LLP
 Arnold & Porter LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
Thayer Capital Partners LP
 Thayer Capital Partners LP Investment ManagersFinance Functions as a private equity firm | Corporate Officer/Principal | - |
Beckman Coulter, Inc.
 Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes biomedical testing instrument systems and general biomedical research products | Direktor/Vorstandsmitglied | - |
Ausbildung von Daniel Raskas
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
70
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Arnold & Porter LLP
Arnold & Porter LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Danaher Corp.
 Danaher Corp. Medical SpecialtiesHealth Technology Provides life sciences and diagnostic services | Health Technology |
OTT Hydromet Corp. (Virginia)
 OTT Hydromet Corp. (Virginia) Electronic Equipment/InstrumentsElectronic Technology Provides hydrological monitoring systems | Electronic Technology |
Tektronix, Inc.
Tektronix, Inc. Electronic Equipment/InstrumentsElectronic Technology Provides test, measurement, and monitoring solutions | Electronic Technology |
Beckman Coulter, Inc.
Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes biomedical testing instrument systems and general biomedical research products | Health Technology |
Sybron Dental Specialties, Inc.
 Sybron Dental Specialties, Inc. Medical SpecialtiesHealth Technology Manufactures and markets dental and medical products | Health Technology |
HCI Equity Partners LLC
HCI Equity Partners LLC Investment ManagersFinance Oridian Capital Partners invests in lower middle market companies located in the United States with an EBITDA of USD 3 - 25 million and revenues ranging USD 20 - 200 million. The firm focuses on a broad range of sectors and Industries. It participates in buyout and growth stage capital requirements with an investment size ranging from USD 15 - 75 million. It also acquires majority stake position. | Finance |
Thayer Capital Partners LP
Thayer Capital Partners LP Investment ManagersFinance Functions as a private equity firm | Finance |
Harvard Law School
 Harvard Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia School of International & Public Affairs
 Columbia School of International & Public Affairs Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Envista Holdings Corp.
 Envista Holdings Corp. Medical SpecialtiesHealth Technology Manufactures and markets dental products | Health Technology |
